万维提示：
1、投稿方式：在线投稿。
2、官网网址：
https://www.sciopen.com/journal/2790-8119
3、投稿系统：
https://mc03.manuscriptcentral.com/nre
4、清华大学出版社期刊中心官网：
https://www.tsinghuajournals.com/cn/journal?id=1
5、出刊日期：季刊，逢季末月出版。
6、官网信息：2025年12月31日之前免收APC费用。
2023年12月26日星期二
Nano Research Energy期刊介绍
【微信公众号信息】
Nano Research Energy(e-ISSN:2790-8119) 作为Nano Research姊妹刊，是清华大学出版社2022年6月创办的全英文开放获取期刊，由曲良体教授（清华大学）和支春义教授（香港城市大学）担任主编，入选了2022年度中国科技期刊卓越行动计划——高起点新刊项目，2025年之前免收APC费用
Nano Research Energy的办刊宗旨是通过出版和传播具有持久价值、卓越见地的研究成果，为纳米材料和纳米科技的发展服务。办刊目标是集聚全世界相关领域最权威的顾问、最敬业的编辑和最优秀的作者，努力建设成为能源领域最具影响力的学术期刊之一。除了发表原创的研究文章外，Nano Research Energy还将发表来自相关领域各方面的研究快报、综述、新闻、专家观点、研究亮点及评论。
能源低碳转型和高质量发展是当前世界面临的重大机遇与挑战，迫切需要深入推进能源生产和消费革命，构建清洁低碳、安全高效能源体系的重要支撑技术。Nano Research Energy作为一本国际化的多学科交叉期刊，聚焦纳米材料和纳米科学技术在新型能源相关领域的前沿研究与应用，包括但不限于电催化和光催化、燃料电池、新型电池技术、先进储能装置、超级电容器、生物能和生物燃料、碳捕集和储存技术、氢能、太阳能、风能、地热能、核能、水能、能源经济、能源安全等主题，对标国际顶级能源期刊，致力于发表高水平的原创性研究和综述类论文，助力“碳达峰、碳中和”目标的实现。
Nano Research Energy 是Nano Research姊妹刊，(ISSN: 2791-0091; e-ISSN: 2790-8119; 官网: https://www.sciopen.com/journal/2790-8119)于2022年6月创刊，由清华大学曲良体教授和香港城市大学支春义教授共同担任主编。Nano Research Energy是一本国际化的多学科交叉，全英文开放获取期刊，聚焦纳米材料和纳米科学技术在新型能源相关领域的前沿研究与应用，对标国际顶级能源期刊，致力于发表高水平的原创性研究和综述类论文，已入选2022年度中国科技期刊卓越行动计划——高起点新刊项目。2025年之前免收APC费用，欢迎各位老师踊跃投稿。
投稿请联系：NanoResearchEnergy@tup.tsinghua.edu.cn
投稿指南Guide for Authors
【官网信息】
1. BEFORE YOU BEGIN
Ethics in publishing
Please see our information on Ethics in Publishing.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Research Council's Guide for the Care and Use of Laboratory Animals and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement in the submitted manuscript even if there are no interests to declare. Author signatures are not required.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. When coding terminology is used, we recommend to avoid offensive or exclusionary terms such as "master", "slave", "blacklist" and "whitelist". We suggest using alternatives that are more appropriate and (self-) explanatory such as "primary", "secondary", "blocklist" and "allowlist". These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Copyright and APC charge
Upon acceptance of an article, authors will be asked to complete an 'Open Access Licence Agreement'. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Open Access Licence Agreement' form or a link to the online version of this agreement. Please note that the Article Processing Charge (APC) of this journal is waived by the end of 2023 or for invited authors.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement, it is recommended to state this.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service by contacting the journal Editorial Office directly at NanoResearchEnergy@tup.tsinghua.edu.cn
2. SUBMISSION
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
……
更多详情：
https://www.sciopen.com/journal/join_journal/for_author?id=1500711144522428418&issn=2791-0091
